ArticleMicrobial cell factories2026
Replication-coupled dual-deaminase mutagenesis (RCDM) enables continuous genomic evolution in Bacillus subtilis.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Bacillus subtilis is an important Generally Recognized as Safe (GRAS) chassis widely used for industrial enzyme production, yet systematic improvement of complex host phenotypes-such as protein secretion capacity-remains difficult using rational engineering alone. Continuous evolution strategies offer a powerful alternative but remain underdeveloped in B. subtilis, largely due to the organism's efficient DNA repair systems that suppress mutagenic intermediates. Here, we report a replication-coupled dual-deaminase mutagenesis platform (RCDM) that enables efficient and continuous genome-wide diversification in B. subtilis. In this system, complementary cytidine and adenine deaminases are tethered to the helicase-loading factor DnaB to access replication-associated single-stranded DNA. Systematic architectural optimization revealed a striking topology dependence of mutagenic activity, where cytidine deamination requires C-terminal fusion whereas adenine deamination is most efficient when fused to the N-terminus of DnaB. Importantly, we show that host DNA repair strongly shapes the mutational output: uracil excision by Ung effectively masks cytidine-derived mutations in dual-deaminase constructs. Co-expression of the uracil-DNA glycosylase inhibitor Ugi alleviates this repair constraint and restores balanced C: G→T: A and A: T→G: C transitions, producing mutation frequencies of (2.80 ± 0.10) × 10⁻⁴ across the genome. To demonstrate the utility of this platform, we coupled α-amylase secretion to growth on soluble starch and performed growth-coupled continuous evolution. Within 20 iterative enrichment cycles, the evolved population exhibited a ~ 30-fold increase in extracellular α-amylase activity relative to the parental strain. Together, these results establish a replication-targeted and repair-aware continuous evolution platform for B. subtilis, providing a versatile strategy for rapid optimization of complex host phenotypes and expanding the continuous evolution toolbox for industrial Gram-positive microbes.
Indexed as
Identifiers
42888422What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.